ChemicalBook >제품 카탈로그 >2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole

2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole

2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole 구조식 이미지

카스 번호:: 202189-77-3

상품명:: 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole

동의어(영문):: Bilastine impurity E;Bilastine Impurity 33;4,5-Dihydrooxazole Bilastine;2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol2yl) piperidin-1-yl) ethyl) phenyl) propan-2-yl)-4,4dimethyl-4,5-;2-(1-(4-(2-(4,4-dimethyl-4,5-dihydrooxazol-2-y l)propan-2-yl)phenethyl)piperidin-4-yl)-1-(2-e thoxyethyl)-1H-benzo[d]imidazole;2-(2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazo;2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole;1H-Benzimidazole, 2-[1-[2-[4-[1-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-1-methylethyl]phenyl]ethyl]-4-piperidinyl]-1-(2-ethoxyethyl)-;2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo [d] imidazole-2-yl) piperidin-1-yl) ethyl) phenyl) propan-2-yl) -4,4-dimethyl-4,5-dihydrooxazole.

CBNumber:: CB83054291

분자식:: C32H44N4O2

포뮬러 무게:: 516.72

MOL 파일:: 202189-77-3.mol

속성

안전

용도

공급 업체 43

2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole 속성

끓는 점: 645.7±55.0 °C(Predicted)

밀도: 1.13±0.1 g/cm3(Predicted)

증기압: 0Pa at 25℃

물리적 상태: 고체

물리적 상태: 단단한 모양

산도 계수 (pKa): 8.73±0.10(Predicted)

안전

위험 및 안전 성명
위험 및 사전주의 사항 (GHS)

그림문자(GHS):

신호 어:

Warning

유해·위험 문구:

암호	유해·위험 문구	위험 등급	범주	신호 어	그림 문자	P- 코드
H341	유전적인 결함을 일으킬 것으로 의심됨 (노출되어도 생식세포 유전독성을 일으키지 않는다는 결정적인 증거가 있는 노출경로가 있다면 노출경로 기재)	생식세포 변이원성 물질	구분 2	경고		P201,P202, P281, P308+P313, P405,P501

예방조치문구:

P201	사용 전 취급 설명서를 확보하시오.
P202	모든 안전 조치 문구를 읽고 이해하기 전에는 취급하지 마시오.
P281	요구되는 개인 보호구를 착용하시오
P308+P313	노출 또는 접촉이 우려되면 의학적인 조치· 조언를 구하시오.
P405	밀봉하여 저장하시오.
P501	...에 내용물 / 용기를 폐기 하시오.

2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole C화학적 특성, 용도, 생산

용도

4,5-Dihydrooxazole Bilastine is an impurity of Bilastine (B385000), which is a novel, nonsedating H1-antihistamine developed for symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.

2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole 준비 용품 및 원자재

원자재

준비 용품

2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole 공급 업체

글로벌( 43)공급 업체

공급자	전화	이메일	국가	제품 수	이점
ShenZhen H&D Pharmaceutical Technology Co., LTD	+86-0755-22677845 +86-13627253706	sale@hdimpurity.com	China	3154	58
Anhui Dexinjia Biopharm Co., Ltd	+86-531-82375818 +8615064153060	sales01@jndxj.com	China	293	58
Qiuxian Baitai New Material Co., LTD	+8618330912755	sale2@hbyalin.com	China	1677	58
ANHUI WITOP BIOTECH CO., LTD	+8615255079626	eric@witopchemical.com	China	23556	58
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12382	58
Huadong Medicine (Xi'an)Bodyguard Pharmaceutical Co.,Ltd.	+86-029-86185165 +8618629664246	guoyuan@eastchinapharm.com	China	1615	58
Zhejiang Hengkang Pharmaceutical Co., Ltd.	+86-576-83372028 +86-18868723926	bd1@hengkangpharm.cn	China	119	58
Jinan Dexinjia Bio&Tech Co., Ltd	+86-0531-82375893 +86-15553111391	sales@jndxj.com	China	1262	58
Changzhou Wanyao Biotechnology Co., Ltd.	0519-89185693 15312551983	2410037592@qq.com	China	282	55
Anhui Dexinjia Biopharm Co., Ltd	0531-8237-5880 15098789112	2710825968@qq.com	China	300	58

2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole 관련 검색:

Benzeneethanol, 4-[1-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-1-methylethyl]-, 4-methylbenzenesulfonate (ester) 2-Propenoic acid, 3-[3-[(phenylaMino)sulfonyl]phenyl]-, Methyl ester, (2E)- Bilastine 4-FORMYLCINNAMIC ACID METHYL ESTER 2-Propenoic acid, 3-[3-[(phenylaMino)sulfonyl]phenyl]-, ethyl ester, (2E)- 2-(1-(4-(2-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)propan- 2-yl)phenethyl)piperidin-4-yl)-1H-benzo[d]imidazole 4-[1-(4,5-DIHYDRO-4,4-DIMETHYL-2-OXAZOLYL)-1-METHYLETHYL]-BENZENEETHANOL